Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency

Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency

US Patent 11512311 · Granted Nov 29, 2022

Estimated economic value: $11,893,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
CRISPR/CAS-related methods and compositions for treating herpes simplex virus2023
CRISPR/cas-related methods and compositions for treating herpes simplex virus2022
Compositions and methods for treating CEP290-associated disease2022
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amau2022
Compositions and methods for treating CEP290-associated disease2021
CRISPR/Cas-related methods and compositions for treating herpes simplex virus2021
Methods and compositions for targeted gene transfer2021
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amau2019
CRISPR/CAS-related methods and compositions for treating leber's congenital amau2018